title: Tender ulceronecrotic nodules in a patient with leukemia. Cutaneous acanthamebiasis.
authors.forename: Sarah N
authors.initials: SN
authors.lastname: Gee
authors.forename: Brian
authors.initials: B
authors.lastname: Rothschild
authors.forename: James
authors.initials: J
authors.lastname: Click
authors.forename: Vaneeta
authors.initials: V
authors.lastname: Sheth
authors.forename: Arturo
authors.initials: A
authors.lastname: Saavedra
authors.forename: Mei-Yu
authors.initials: MY
authors.lastname: Hsu
mesh_terms: D000048:Acanthamoeba / Q000187:drug effects; D000562:Amebiasis / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications*; D008875:Middle Aged; D009336:Necrosis; D010419:Pentamidine / Q000627:therapeutic use; D010767:Phosphorylcholine / Q000031:analogs & derivatives / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D012876:Skin Diseases, Parasitic / Q000188:drug therapy / Q000469:parasitology / Q000473:pathology*; D012883:Skin Ulcer / Q000188:drug therapy / Q000469:parasitology / Q000473:pathology*; D013413:Sulfadoxine / Q000627:therapeutic use; D014230:Triazoles / Q000627:therapeutic use; D065819:Voriconazole
chemical_list: D000981:Antiprotozoal Agents; D011743:Pyrimidines; D014230:Triazoles; D010767:Phosphorylcholine; C039128:miltefosine; D010419:Pentamidine; D013413:Sulfadoxine; D015725:Fluconazole; D005437:Flucytosine; D065819:Voriconazole